GameStop: Consensus Estimates Point To Negative EBITDA For Q3

GameStop (NYSE: GME) will be reporting its third quarter financial results on December 8th after the market closes. Analysts have a consensus $88 12-month price target on the company, via a total of 3 analysts, with 1 analyst having a hold rating, another analyst having a sell rating, and the last analyst having a strong sell rating. The street high comes in at a $190 price target, and the lowest target sits at $24.

Only 4 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 4 analysts is $1.19 billion; this number has been up and down but is flat now since early June. The highest revenue estimate is $1.30 billion, while the lowest is $1.01 billion.

Onto EBITDA estimates, there are currently only 2 analysts who have third quarter EBITDA estimates. The mean is currently -$15 million, with this number being slightly revised lower since early June. The street high estimate currently sits at $12 million in EBITDA and the lowest is -$42 million.

Analysts estimate that quarterly earnings per share will come in at -$0.52, with this number being flat since early June. Street high is -$0.04 and the lowest estimate is -$0.87 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Japan Gold Intersects Gold Mineralization Drilling At Mizobe, Encounters Banded Chalcedony Vein

Antimony Resources Drills 5.10% Sb Over 4.0 Metres At Bald Hill

Related News

Magna: BMO Expects A Poor Quarter After Conducting Channel Checks

Magna International (TSX: MG) is expected to report its third-quarter financial results on November 5th...

Friday, October 29, 2021, 07:33:00 AM

Canaccord: The Bottom For Gold Is Near

Canaccord Genuity Capital Markets on Monday issued an industry update on precious metals, where they...

Saturday, November 19, 2022, 01:29:00 PM

Canaccord Raises Greenlane Renewables Price Target To $2.75

Canaccord upgraded Greenlane Renewables (TSXV: GRN) from C$1.60 to C$2.75 and reiterated their speculative buy...

Friday, January 8, 2021, 11:53:00 AM

MediPharm Labs: Canaccord Slashes Price Target Following Q4 Results

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial...

Friday, April 2, 2021, 09:00:00 AM

Harvest Health: Canaccord Reiterates Price Target Following Earnings

On August 10, Harvest Health and Recreation (CSE: HARV) reported its second quarter results. The...

Thursday, August 12, 2021, 03:49:00 PM